Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (141-150 of 272) with videos related to

Pageof 28
Sort By:
Cancer Chemotherapy and Pharmacology|June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerAmita Patnaik, Michael Gordon, Frank Tsai, et al.
Anticancer Research|April 30, 2014
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials programMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Antimalarial 2-Pyrazolyl Quinolone <i>bc</i> <sub>1</sub> (Q<sub>i</sub>) Inhibitors with Improved Drug-like PropertiesW David Hong, Suet C Leung, Kangsa Amporndanai, et al.
Cancer Chemotherapy and Pharmacology|July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerAmita Patnaik, Michael Gordon, Frank Tsai, et al.
Bioorganic Chemistry|January 8, 2021
Oleanolic acid indole derivatives as novel α-glucosidase inhibitors: Synthesis, biological evaluation, and mechanistic analysisPanpan Wu, Hao He, Hang Ma, et al.
Chemical Science|December 12, 2024
A diazirine's central carbon is sp<sup>2</sup>-hybridized, facilitating conjugation to dye moleculesLorenzo Michelini, Tanya Slaney, Seerat Virk, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Liquid biopsies in lung cancer: the new ambrosia of researchersChristian Rolfo, Marta Castiglia, David Hong, et al.
JACC. Asia|December 15, 2022
Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary InterventionDavid Hong, Seung Hun Lee, Doosup Shin, et al.
ESMO Open|November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trialsAndrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Pageof 28

Showing results (141-150 of 272) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerAmita Patnaik, Michael Gordon, Frank Tsai, et al.
Anticancer Research|April 30, 2014
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials programMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Antimalarial 2-Pyrazolyl Quinolone <i>bc</i> <sub>1</sub> (Q<sub>i</sub>) Inhibitors with Improved Drug-like PropertiesW David Hong, Suet C Leung, Kangsa Amporndanai, et al.
Cancer Chemotherapy and Pharmacology|July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerAmita Patnaik, Michael Gordon, Frank Tsai, et al.
Bioorganic Chemistry|January 8, 2021
Oleanolic acid indole derivatives as novel α-glucosidase inhibitors: Synthesis, biological evaluation, and mechanistic analysisPanpan Wu, Hao He, Hang Ma, et al.
Chemical Science|December 12, 2024
A diazirine's central carbon is sp<sup>2</sup>-hybridized, facilitating conjugation to dye moleculesLorenzo Michelini, Tanya Slaney, Seerat Virk, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Liquid biopsies in lung cancer: the new ambrosia of researchersChristian Rolfo, Marta Castiglia, David Hong, et al.
JACC. Asia|December 15, 2022
Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary InterventionDavid Hong, Seung Hun Lee, Doosup Shin, et al.
ESMO Open|November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trialsAndrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Pageof 28